|
Martinez-Garcia, J; Boix, AP; Henarejos, PS; Lucas, MDJ; Saura, AS; Luengo, M; Vicente, RC; Ortiz, MJM; Balsalobre, J; Barrio, PDLMD; Garre, EG; Garcia, E; Marin, G; Torralba, EG; de la Pena, FA; Collado, D; Lopez, A; Quiros, T; Sanchez, DA; Romero, JLA. Trastuzumab emtansine in HER2-positive metastatic breast cancer after pertuzumab and trastuzumab: TDM1RM Study. ANNALS OF ONCOLOGY. 2020; 31:S358-S358. 10.1016/j.annonc.2020.08.393
AÑO: 2020; IF: 32.976
|
|
Antonio CCP, Alida GG, Elena GG, Rocio GS, Jeronimo MG, Luis ARJ, Anibal ND, Francisco BV, Jesus GRA, Pablo RR, Jose GM. Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial. Ann Surg Oncol. 2022 Apr;29(4):2617-2625. doi: 10.1245/s10434-021-11087-7. Epub 2021 Nov 23. PubMed PMID: 34812982.
AÑO: 2022; IF: 3.7
|
|
Castillo-Guardiola V, Rosado-Jimenez L, Sarabia-Meseguer MD, Marin-Vera M, Macias-Cerrolaza JA, Garcia-Hernandez R, Zafra-Poves M, Sanchez-Henarejos P, Moreno-Locubiche MA, Cuevas-Tortosa E, Arnaldos-Carrillo M, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance. Eur J Med Genet. 2022 Apr;65(4):104468. doi: 10.1016/j.ejmg.2022.104468. Epub 2022 Mar 1. PubMed PMID: 35245693.
AÑO: 2022; IF: 1.9
|
|
Sanchez Martinez DA, Salas-Lucia F, Jiang H, Ruiz-Carreno P, Alonso Romero JL. Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact. BMC Health Serv Res. 2022 Jul 26;22(1):948. doi: 10.1186/s12913-022-08222-9. PubMed PMID: 35883128; PubMed Central PMCID: PMC9316356.
AÑO: 2022; IF: 2.908
|
|
Rosado-Jimenez L, Mestre-Terkemani Y, Garcia-Aliaga A, Marin-Vera M, Macias-Cerrolaza JA, Sarabia-Meseguer MD, Garcia-Hernandez MR, Zafra-Poves M, Sanchez-Henarejos P, Ayala de la Pena F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Variantes geneticas recurrentes y priorizacion de variantes de significado clinico desconocido asociadas al sindrome de cancer de mama y ovario hereditario en familias de la Region de Murcia. Adv Lab Med. 2023 Jul 10;4(3):288-297. doi: 10.1515/almed-2023-0032. eCollection 2023 Sep. Spanish. PubMed PMID: 38075173; PubMed Central PMCID: PMC10701495.
AÑO: 2023; IF: 1.0
|